White Paper
The 340B Drug Discount Program: Complexity, Challenges, and Change
Learn more about the 340B program, how it's evolving, potential challenges, and possible strategies to mitigate its impact on gross-to-net.
Sep 01, 2020
The combination of COVID-19, specialty growth,the rise of contract pharmacies, and more effective covered entity strategies is creating a perfect storm for manufacturers. It is vital they understand the 340B program and arm themselves with solutions that shed light on how it is impacting their business and develop more advanced strategies to ensure proper program usage. This is the first in a series of articles about the 340B program from IQVIA's Market Access Center of Excellence (CoE).